Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMC 177767)

Published in J Bacteriol on February 01, 1996

Authors

V Aragón1, R Díaz, E Moreno, I Moriyón

Author Affiliations

1: Departamento de Microbiología, Universidad de Navarra, Pamplona, Spain.

Articles citing this

Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect Immun (1998) 2.55

Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One (2007) 1.82

The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci U S A (2002) 1.77

Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J Bacteriol (1996) 1.47

Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. PLoS One (2008) 1.37

Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infect Immun (2003) 1.29

MyD88, but not toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus. Infect Immun (2005) 1.24

Characterization of new members of the group 3 outer membrane protein family of Brucella spp. Infect Immun (2003) 1.19

The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides. J Bacteriol (2005) 1.17

Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance. Infect Immun (2000) 1.17

Efficacy of several serological tests and antigens for diagnosis of bovine brucellosis in the presence of false-positive serological results due to Yersinia enterocolitica O:9. Clin Diagn Lab Immunol (2005) 1.09

The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains. Infect Immun (1999) 1.09

Antigenic characterization of the fish pathogen Flavobacterium psychrophilum. Appl Environ Microbiol (2001) 1.08

Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis. Clin Diagn Lab Immunol (2003) 1.07

Molecular characterization of a Brucella species large DNA fragment deleted in Brucella abortus strains: evidence for a locus involved in the synthesis of a polysaccharide. Infect Immun (1999) 0.99

Evaluation of lipopolysaccharides and polysaccharides of different epitopic structures in the indirect enzyme-linked immunosorbent assay for diagnosis of brucellosis in small ruminants and cattle. Clin Diagn Lab Immunol (1998) 0.98

Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness. Infect Immun (2005) 0.95

Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells. Infect Immun (2007) 0.95

Proteomics-based confirmation of protein expression and correction of annotation errors in the Brucella abortus genome. BMC Genomics (2010) 0.92

Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells. PLoS Pathog (2012) 0.92

Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes. Infect Immun (1999) 0.91

The epitopic and structural characterization of Brucella suis biovar 2 O-polysaccharide demonstrates the existence of a new M-negative C-negative smooth Brucella serovar. PLoS One (2013) 0.90

Release of periplasmic proteins of Brucella suis upon acidic shock involves the outer membrane protein Omp25. Infect Immun (2004) 0.89

The type IV secretion system component VirB5 binds to the trans-zeatin biosynthetic enzyme Tzs and enables its translocation to the cell surface of Agrobacterium tumefaciens. J Bacteriol (2007) 0.83

Lipopolysaccharides of Brucella abortus and Brucella melitensis induce nitric oxide synthesis in rat peritoneal macrophages. Infect Immun (2000) 0.82

Performance of competitive and indirect enzyme-linked immunosorbent assays, gel immunoprecipitation with native hapten polysaccharide, and standard serological tests in diagnosis of sheep brucellosis. Clin Diagn Lab Immunol (1999) 0.82

Deletion of the GI-2 integrase and the wbkA flanking transposase improves the stability of Brucella melitensis Rev 1 vaccine. Vet Res (2013) 0.81

Serological diagnosis of Brucella infections in odontocetes. Clin Vaccine Immunol (2009) 0.78

Structural Studies of Lipopolysaccharide-defective Mutants from Brucella melitensis Identify a Core Oligosaccharide Critical in Virulence. J Biol Chem (2016) 0.77

The "missing" typical Rhizobium leguminosarum O antigen is attached to a fatty acylated glycerol in R. leguminosarum bv. trifolii 4S, a strain that also lacks the usual tetrasaccharide "core" component. J Bacteriol (1996) 0.76

N-Formyl-Perosamine Surface Homopolysaccharides Hinder the Recognition of Brucella abortus by Mouse Neutrophils. Infect Immun (2016) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem (1978) 38.54

A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem (1982) 36.39

A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem (1980) 24.76

A dot-immunobinding assay for monoclonal and other antibodies. Anal Biochem (1982) 15.84

Preparation and host-reactive properties of endotoxin with low content of nitrogen and lipid. J Exp Med (1961) 3.84

Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol (1979) 3.40

Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria. J Bacteriol (1990) 3.36

Some structural and biological properties of Brucella endotoxin. Infect Immun (1970) 3.26

Surface antigens of smooth brucellae. J Bacteriol (1968) 3.24

Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3. Infect Immun (1984) 3.10

Ultrastructural localization of antigenic sites on osmium-fixed tissues applying the protein A-gold technique. J Histochem Cytochem (1983) 2.63

Radial immunodiffusion test with a Brucella polysaccharide antigen for differentiating infected from vaccinated cattle. J Clin Microbiol (1979) 2.55

High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli. J Bacteriol (1985) 2.46

Effects of nonionic, ionic, and dipolar ionic detergents and EDTA on the Brucella cell envelope. J Bacteriol (1982) 2.00

Cyclic beta-glucans of members of the family Rhizobiaceae. Microbiol Rev (1994) 2.00

Immunochemical characterization of Brucella lipopolysaccharides and polysaccharides. Infect Immun (1981) 1.96

Amplification fragment length polymorphism in Brucella strains by use of polymerase chain reaction with arbitrary primers. J Bacteriol (1992) 1.93

Fine structure of A and M antigens from Brucella biovars. Infect Immun (1989) 1.90

The structure of the O-antigenic side chain of the lipopolysaccharide of Vibrio cholerae 569B (Inaba). Biochim Biophys Acta (1979) 1.85

A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum. J Bacteriol (1982) 1.84

Miniaturization of three carbohydrate analyses using a microsample plate reader. Anal Biochem (1991) 1.65

The structure of the lipopolysaccharide O-chain (M antigen) and polysaccharide B produced by Brucella melitensis 16M. FEBS Lett (1987) 1.58

Evaluation of a radial immunodiffusion test with polysaccharide B antigen for diagnosis of bovine brucellosis. J Clin Microbiol (1980) 1.50

An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination. Vet Microbiol (1992) 1.50

Immunochemical characterization of rough Brucella lipopolysaccharides. Infect Immun (1984) 1.45

Characterization of Brucella abortus soluble antigen employed in immunoassay. J Clin Microbiol (1980) 1.43

Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats. J Clin Microbiol (1993) 1.38

Release of outer membrane fragments by exponentially growing Brucella melitensis cells. Infect Immun (1987) 1.32

Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats. J Clin Microbiol (1994) 1.31

Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol (1994) 1.31

A simple method for the extraction of polysaccharide B from Brucella cells for use in the radial immunodiffusion test diagnosis of bovine brucellosis. Ann Rech Vet (1981) 1.26

Immunological identity of brucella native hapten, polysaccharide B, and yersinia enterocolitica serotype 9 native hapten. Infect Immun (1982) 1.19

Immunochemical studies of polysaccharide surface antigens of Escherichia coli 0100:K?(B):H2. Eur J Biochem (1970) 1.19

Purified native haptens of Brucella abortus B19 and B. melitensis 16M reveal the lipopolysaccharide origin of the antigens. Ann Inst Pasteur Microbiol (1988) 1.08

Characterization of a native polysaccharide hapten from Brucella melitensis. Infect Immun (1987) 1.03

Structural and immunochemical characterization of the O-haptens of Brucella abortus lipopolysaccharides from strains 19 and 2308. Mol Cell Biochem (1987) 1.01

Structure of the Escherichia coli 0104 polysaccharide and its identity with the capsular K9 polysaccharide. FEMS Microbiol Lett (1992) 0.98

Brucella group 3 outer membrane proteins contain a heat-modifiable protein. FEMS Microbiol Lett (1993) 0.97

Capsule structure of Proteus mirabilis (ATCC 49565). J Bacteriol (1992) 0.95

Evaluation of polysaccharide, lipopolysaccharide, and beta-glucan antigens in gel immunodiffusion tests for brucellosis in cattle. Am J Vet Res (1992) 0.91

[Carboyydrates localization on ultrathin sections of "Brucella" and "Escherichia" cells in smooth (S) and rough (R) phase (author's transl)]. Ann Microbiol (Paris) (1977) 0.88

[Molecular nature of the Brucella polysaccharide antigen (poly-B)]. Bioorg Khim (1987) 0.87

[Somatic antigens of the Brucella genus. The structure of the O-specific polysaccharide chain of Brucella melitensis lipopolysaccharide]. Bioorg Khim (1985) 0.86

Purification of nonlipopolysaccharide antigen from Brucella abortus during preparation of antigen used for indirect hemolysis test. J Clin Microbiol (1986) 0.83

A sensitive blotting system for detection of alpha-fetoprotein variants with monoclonal and polyclonal antibodies. J Immunol Methods (1988) 0.80

Demonstration of an external layer in several species of the genus Brucella. Can J Microbiol (1982) 0.77

Articles by these authors

Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect Immun (1998) 3.92

Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol (1979) 3.40

Visualization of gene expression in living adult Drosophila. Science (1996) 2.92

A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol Microbiol (1998) 2.60

Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57

Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect Immun (1998) 2.55

Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat Cell Biol (1999) 2.17

Biological activities of Brucella abortus lipopolysaccharides. Infect Immun (1981) 2.13

Evaluation of the relatedness of Brucella spp. and Ochrobactrum anthropi and description of Ochrobactrum intermedium sp. nov., a new species with a closer relationship to Brucella spp. Int J Syst Bacteriol (1998) 2.11

Nucleotide sequence of the 16S rRNA from Brucella abortus. Nucleic Acids Res (1989) 2.05

Immunochemical characterization of Brucella lipopolysaccharides and polysaccharides. Infect Immun (1981) 1.96

Identification of components of a new stability system of plasmid R1, ParD, that is close to the origin of replication of this plasmid. Mol Gen Genet (1987) 1.88

The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect Immun (1995) 1.82

The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci U S A (2002) 1.77

Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol (1992) 1.74

[Validity of the protocol for evaluating the inappropriate use of hospitalization]. Med Clin (Barc) (1996) 1.70

Double versus single renal allografts from aged donors. Transplantation (2000) 1.58

Monochromatic aberrations and point-spread functions of the human eye across the visual field. J Opt Soc Am A Opt Image Sci Vis (1998) 1.56

Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3. The ECLA Collaborative Group. Am Heart J (1999) 1.56

Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer. Lymphology (1999) 1.51

Evaluation of a radial immunodiffusion test with polysaccharide B antigen for diagnosis of bovine brucellosis. J Clin Microbiol (1980) 1.50

An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination. Vet Microbiol (1992) 1.50

Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect (2006) 1.49

Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology (1997) 1.48

Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48

Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J Bacteriol (1996) 1.47

Immunochemical characterization of rough Brucella lipopolysaccharides. Infect Immun (1984) 1.45

A new species of Leishmania parasite from the Venezuelan Andes region. Trans R Soc Trop Med Hyg (1979) 1.43

The immune spectrum in patients with pulmonary tuberculosis. Am Rev Respir Dis (1981) 1.43

Characterization of Brucella abortus soluble antigen employed in immunoassay. J Clin Microbiol (1980) 1.43

The Myf fibrillae of Yersinia enterocolitica. Mol Microbiol (1993) 1.42

[Caroli disease: a case report and review of literature]. Acta Gastroenterol Latinoam (1998) 1.39

[Laparoscopic cholecystectomy without pneumoperitoneum. A review of 150 cases]. Acta Gastroenterol Latinoam (2000) 1.39

Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg (1996) 1.39

Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats. J Clin Microbiol (1993) 1.38

Primary extragastrointestinal stromal tumors in the omentum and mesentery: a clinicopathological and immunohistochemical study. Hepatogastroenterology (2008) 1.38

Half-life of the plasma membrane ATPase and its activating system in resting yeast cells. Biochim Biophys Acta (1991) 1.33

Release of outer membrane fragments by exponentially growing Brucella melitensis cells. Infect Immun (1987) 1.32

Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. Infect Immun (1989) 1.32

Brucella abortus lipopolysaccharide is mitogenic for spleen cells of endotoxin-resistant C3H/HeJ mice. J Immunol (1979) 1.32

Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats. J Clin Microbiol (1994) 1.31

Killing of Escherichia coli cells modulated by components of the stability system ParD of plasmid R1. Mol Gen Genet (1988) 1.31

Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol (1994) 1.31

Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infect Immun (2003) 1.29

GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: direct activation of Cdc42. J Biol Chem (2001) 1.27

Antibody response to Brucella ovis outer membrane proteins in ovine brucellosis. Infect Immun (1990) 1.27

Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet (1993) 1.25

Identification of 2,3-dihydroxybenzoic acid as a Brucella abortus siderophore. Infect Immun (1992) 1.24

Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. J Immunol (2000) 1.24

The lipopolysaccharide outer core of Yersinia enterocolitica serotype O:3 is required for virulence and plays a role in outer membrane integrity. Mol Microbiol (1999) 1.24

Prism adaptation and aftereffect: specifying the properties of a procedural memory system. Learn Mem (1999) 1.23

Characterization of a Yersinia enterocolitica antigen common to enterocolitis-associated serotypes. J Clin Microbiol (1985) 1.23

Enzyme immunoassays for serological diagnosis of bovine brucellosis: A trial in Latin America. Clin Diagn Lab Immunol (1998) 1.23

Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22

The outer membranes of Brucella spp. are not barriers to hydrophobic permeants. J Bacteriol (1993) 1.20

[Contribution to the serological diagnosis of brucellosis and yersiniosis. I. Use of the gel precipitation reaction]. Rev Clin Esp (1971) 1.20

Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect Immun (1992) 1.20

Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance. Infect Immun (2000) 1.17

Demonstration of a peptidoglycan-linked lipoprotein and characterization of its trypsin fragment in the outer membrane of Brucella spp. Infect Immun (1986) 1.16

Entanglement of two qubits mediated by one-dimensional plasmonic waveguides. Phys Rev Lett (2011) 1.15

Comparison of lipopolysaccharide and outer membrane protein-lipopolysaccharide extracts in an enzyme-linked immunosorbent assay for the diagnosis of Brucella ovis infection. J Clin Microbiol (1986) 1.14

Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J Immunol (1999) 1.12

Factors affecting detection of Brucella melitensis by BACTEC NR730, a nonradiometric system for hemocultures. J Clin Microbiol (1993) 1.12

Brucella lipopolysaccharides and polysaccharides. Ann Inst Pasteur Microbiol (1987) 1.11

Invasion and intracellular trafficking of Brucella abortus in nonphagocytic cells. Microbes Infect (2000) 1.11

Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide. Infect Immun (1984) 1.10

Efficacy of several serological tests and antigens for diagnosis of bovine brucellosis in the presence of false-positive serological results due to Yersinia enterocolitica O:9. Clin Diagn Lab Immunol (2005) 1.09

Evaluation of allergic and serological tests for diagnosing Brucella melitensis infection in sheep. J Clin Microbiol (1994) 1.09

The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains. Infect Immun (1999) 1.09

Genetic and functional analysis of the basic replicon of pPS10, a plasmid specific for Pseudomonas isolated from Pseudomonas syringae patovar savastanoi. J Mol Biol (1992) 1.09

Properties of the outer membrane of Brucella. Ann Inst Pasteur Microbiol (1987) 1.08

[Invasive fungal infections in liver transplant recipients: analysis of 21 cases]. Med Clin (Barc) (1998) 1.07

Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation. Leukemia (2007) 1.06

Modulation of endocytosis in nuclear factor IL-6(-/-) macrophages is responsible for a high susceptibility to intracellular bacterial infection. J Immunol (1999) 1.05

Regulation of Brucella virulence by the two-component system BvrR/BvrS. Vet Microbiol (2002) 1.05

The depth-of-field of the human eye from objective and subjective measurements. Vision Res (1999) 1.05

Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. J Biol Chem (1994) 1.04

Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. Mol Psychiatry (2011) 1.04

Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol (2005) 1.03

Heterogeneity of Brucella abortus lipopolysaccharides. Res Microbiol (1995) 1.01

Brucella outer membrane lipoprotein shares antigenic determinants with Escherichia coli Braun lipoprotein and is exposed on the cell surface. Infect Immun (1987) 1.01

An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol (2001) 1.01

Yersinia pseudotuberculosis and Yersinia pestis are more resistant to bactericidal cationic peptides than Yersinia enterocolitica. Microbiology (1998) 1.00